1[1]Adams DJ, Knick VC. P-glycoprotein mediated resistance to 5'-nor- anhydrovinblastine(Navelbine). Invest New Drugs, 1995;13(1)∶13
2[2]O'Rourke M, Crawford J, Sichiller J, et al. Survival advantage for patients with stage Ⅳ NSCLC treated with single agent navelbine in a randomized controlled trail. Proc Am Soc Clin Oncol,1995;12(2)∶243
3[3]Depoierre A, Chastang C, Quoix E, et al. Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial. Ann Oncol,1994;5 (1)∶37
